← Leaderboards
Holger Karsunky
Cellerant Therapeutics, Inc.
$3,179,282
Attributed
$3,179,282
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$3,179,282 · 4
By mechanism
N01$1,489,036 · 1
RC1$1,000,000 · 1
R43$690,246 · 2
Top collaborators
No co-investigators on record.
Most similar at Cellerant Therapeutics, Inc.
Same institution · by research overlap
- Julie L. Christensen$594,835
- Adrianus G.w. Domen$658,973
- Timothy Cheng Fong$100,394
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProductionMegakaryocytesToxic EffectSafetyProgenitorIn VivoManufacturing ProcessRadiationThrombocytopeniaHemorrhageClinical ResearchCd34 GeneClinical TrialsBlood PlateletsGrowth FactorAllogenicEventBlood CirculationHematopoietic SystemAutologousHematopoietic Stem CellsDevelopmental Therapeutics ProgramAnimals
Grant awards (5)
Development of a Process for Generating Human MKP$1,489,036
N01 · FY2013 · CA · contact PI
Development of ex vivo Expanded Megakaryocyte Progenitors for Platelet Recovery F$500,000
RC1 · FY2009 · AI · contact PI
Development of ex vivo Expanded Megakaryocyte Progenitors for Platelet Recovery F$500,000
RC1 · FY2008 · AI · contact PI
Expansion of HSC for rescue in biodefense applications$393,363
R43 · FY2005 · AI
Application of expanded progenitors against infections$296,883
R43 · FY2005 · AI